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Abstract Pulsed low intensity ultrasound (PLIUS) has
been used successfully for bone fracture repair and has
therefore been suggested for cartilage regeneration. How-
ever, previous in vitro studies with chondrocytes show
conﬂicting results as to the effect of PLIUS on the elabo-
ration of extracellular matrix. This study tests the hypoth-
esis that PLIUS, applied for 20 min/day, stimulates the
synthesis of sulphated glycosaminoglycan (sGAG) by adult
bovine articular chondrocytes cultured in either monolayer
or agarose constructs. For both culture models, PLIUS at
either 30 or 100 mW/cm
2 intensity had no net effect on the
total sGAG content. Although PLIUS at 100 mW/cm
2 did
induce a 20% increase in sGAG content at day 2 of culture
in agarose, this response was lost by day 5. Intensities of
200 and 300 mW/cm
2 resulted in cell death probably due
to heating from the ultrasound transducers. The lack of a
sustained up-regulation of sGAG synthesis may reﬂect the
suggestion that PLIUS only induces a stimulatory effect in
the presence of a tissue injury response. These results
suggest that PLIUS has a limited potential to provide an
effective method of stimulating matrix production as part
of a tissue engineering strategy for cartilage repair.
Keywords LIPUS  PLIUS  Cartilage 
Glycosaminoglycan  Ultrasound
1 Introduction
Pulsed low intensity ultrasound (PLIUS), also known as
low intensity pulsed ultrasound (LIPUS), has clinically
been shown to enhance the healing of fresh fractures and
bony non-unions [16, 22]. The mode of action is unclear,
although exciting new studies indicate that ultrasound
activates the canonical Wnt signalling pathway which is
important for osteoblast function [34]. Other studies sug-
gest that ultrasound may stimulate bone healing processes
such as endochondral ossiﬁcation [37, 41], involving the
earlier expression of cartilage speciﬁc genes [44]. Conse-
quently, PLIUS may also be beneﬁcial for cartilage
regeneration either in vivo or as part of an in vitro tissue
engineered approach [6, 17, 29].
The acoustic pressure waves produced by PLIUS can be
considered as high-frequency micromechanical perturba-
tions that may have a direct mechanical effect on exposed
cells. Indeed, the resulting cellular and intracellular chan-
ges may be similar to those seen with more physiological
low frequency cyclic compression of chondrocytes in car-
tilage explants [12] or biomaterial scaffolds [5, 24, 28].
Several in vitro studies have been undertaken to charac-
terise the effects of PLIUS on chondrocytes in both
monolayer and 3D model systems. These studies report
upregulation of aggrecan and collagen II genes [30, 35, 45],
GAG synthesis [20, 32], calcium signalling [36], and
integrin expression [18]. However, conﬂicting reports
suggest that PLIUS induces, at best, a transient effect on
chondrocyte culture systems in terms of aggrecan gene
expression [46], and GAG and collagen II production
[17, 21]. Furthermore, a study involving the implantation
of a tissue-engineered scaffold into nude mice indicated
that PLIUS had no effect on cartilage matrix production, as
assessed by histological staining, and an inhibitory effect
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expression and tissue biomechanics [10]. The literature is
therefore ambiguous regarding the inﬂuence of PLIUS on
articular chondrocytes and the possible acceleration of
chondrogenic pathways.
This study examines the inﬂuences of PLIUS on adult
articular chondrocytes cultured both in monolayer and
within the well-established 3D agarose model. Initial
studies investigated the effect of PLIUS intensity on the
viability of chondrocytes within the agarose gel. Thereaf-
ter, two different intensities, 30 and 100 mW/cm
2, were
selected to test the hypothesis that PLIUS stimulates the
synthesis and elaboration of sGAG over a 16-day culture
period, and that this response is inﬂuenced by the intensity
of the ultrasound. The synthesis of sGAG was quantiﬁed by
measuring both the total sGAG content, using the DMB
assay, and the synthesis of new sGAG, using incorporation
of radiolabelled SO4.
2 Materials and methods
2.1 Preparation of chondrocyte cultures
Chondrocytes were isolated from the metacarpophalangeal
joint of skeletally mature, 18–24 month old steers and
seeded in agarose using a well-established method [24].
Culture media (DMEM ? 20% FCS) consisted of high
glucose Dulbecco’s Modiﬁed Eagles Medium (DMEM)
supplemented with L-glutamine (2 lM), L-ascorbate
(0.85 lM), penicillin (5 lg/ml), streptomycin (5 lg/ml),
HEPES (20 mM) and 16.1% (v/v) foetal calf serum (FCS).
All reagents were from Sigma-Aldrich UK, unless other-
wise stated. Full depth cartilage from the proximal surface
of the joint was extracted and sequentially digested at 37C
for 1 h in 700 units/ml of pronase (Type E, BDH Ltd., UK)
followed by 16 h in 100 units/ml of collagenase (Type XI-
A), both prepared in DMEM ? FCS. The explant digest
was passed through a cell sieve, and the resulting cell
suspension was washed twice with fresh DMEM ? FCS.
Thereafter, cell number and viability were assessed using
trypan blue and a haemocytometer. In total, data were
collected from six separate chondrocyte isolations, with
cells pooled from four to six individual joints for each
isolation.
For 3D agarose cultures, the isolated cells were seeded
in 3% low gelling agarose (type VII) at 4 9 10
6 cells/ml.
Using a positive displacement pipette, each well of a
standard six-well culture plate was ﬁlled with 3.3 ml of the
cell–agarose suspension to yield a layer of cell–agarose gel
3 mm in height. Subsequent to gelation at 4C for 20 min,
the cell–agarose layer in each well was covered with
6.6 ml of DMEM ? FCS and cultured for 24 h at 37C
and 5% CO2 before experimentation. For monolayer cul-
tures, cells were seeded directly into the wells of a standard
six-well culture plate at a density of 100 9 10
3 cells/cm
2
as used previously [35]. Each well, containing approxi-
mately 1 million cells, was ﬁlled with 6 ml of DMEM ?
FCS. All the cultures were maintained at 37C and 5% CO2
within a humidiﬁed cell culture incubator with media
changed every 1–3 days.
2.2 PLIUS system
PLIUS was generated using a calibrated Exogen system
provided by Smith and Nephew Inc. (York, UK). This
delivered an ultrasound signal with Spatial Average and
Temporal Average (SATA) intensities between 30 and
300 mW/cm
2, and a sinusoidal waveform of frequency of
1.5 MHz with a 200-ls pulse burst repeating at 1.0 kHz, as
previously described [33]. The ultrasonic driver box con-
trolled six transducers mounted in a frame speciﬁcally for
use with a standard six-well culture plate [35]. PLIUS was
produced at the transducers and transmitted through the
bottom of the wells of a six-well plate with the use of
coupling gel (Exogen, Piscataway, USA). For all the
studies, PLIUS stimulation was applied once a day for a
20-min period.
2.3 Inﬂuence of PLIUS intensity on cell viability
Chondrocyte–agarose gels were cultured for 9 days, during
which they were subjected to 20 min of PLIUS once a day
at SATA intensities of either 30, 100, 200 or 300 mW/cm
2.
For assessment of cell viability, a single cylindrical con-
struct, 6 mm in diameter, was removed from the central
region of each well at the end of the 9-day culture period.
The construct was cut longitudinally and incubated for
45 min in 0.6 ml of DMEM ? FCS supplemented with
Calcein-AM (5 lM, Molecular Probes, UK) and Ethidium
homodimer-2 (5 lM, Molecular Probes, UK) to label the
live and dead cells, respectively. Thereafter, each half
construct was washed and mounted with its cut surface on a
cover slip and visualised with a ﬂuorescent microscope
(Eclipse, Nikon, Kingston-upon-Thames, UK) with a 920
objective. Viability was recorded by a systematic sampling
of the construct, using a standard eye piece graticule
sampling area of 0.5 9 0.25 mm
2. Adjacent sampling
areas were examined, proﬁling from the top of each con-
struct down to the base closest to the PLIUS transducer.
The number of live (green) and dead (red) cells were
counted in each sampling area and the percentage viability
calculated. The procedure was repeated (n = 3) for each
construct.
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To quantify the inﬂuence of PLIUS on elaboration of
sGAG, chondrocytes in both agarose and monolayer cul-
tures were subjected daily, to a 20-min period of PLIUS at
a SATA intensity of 30 or 100 mW/cm
2. Initial exposure of
the agarose constructs occurred after 24 h of culture. By
contrast, monolayer cultures were ﬁrst incubated for 96 h
to enable cells to become fully attached to the plastic
substrate, in keeping with previous studies by Parvezi et al.
[35]. Non-stimulated controls in separate six-well plates,
were identically treated but without exposure to PLIUS.
Media were changed every 1–3 days and frozen for
subsequent analysis. For agarose cultures, 6-mm-diameter
cylindrical constructs (n = 6) were removed from the
centre of a single well on days 1, 2, 5, 9, 12 and 16 and
stored frozen. At the end of each experiment, the constructs
were thawed and digested in 560 units/ml papain and
1000 units/ml agarase (both Sigma-Aldrich, Poole, UK).
For monolayer cultures at days 4, 6 and 8, the media were
removed, and the cell extract processed separately, fol-
lowing protocols described by Parvezi et al. [35].
The entire procedure for both PLIUS intensity settings,
was repeated using separate chondrocyte isolations (n = 3
for agarose and n = 2 for monolayer). At each time point,
data was normalised to the corresponding controls to
account for any inherent biological variation between the
animals used in the replicate experiments.
2.5 Biochemical analysis
Total sGAG contents in the agarose constructs, the
monolayer samples and all the associated media were
determined using the DMB method [11]. The sGAG values
for the media were summed to give cumulative sGAG
released into the media. In order to estimate the amount of
sGAG released from each cylindrical agarose construct, the
cummulative level of sGAG in the media for each well was
multiplied by the ratio of the cross-sectional area of the
agarose construct divided by the area of the well.
2.6 Radioisotope incorporation
Radioisotope incorporation assays were used to determine
the rate of sGAG synthesis over speciﬁc 24-h time periods
following established protocols [24]. For agarose con-
structs on days 1, 4, 8, 11 and 15, the media were removed
from the wells and replaced with fresh media supplemented
with 10 lCi/ml
35SO4 (Amersham Biosciences, UK). The
media were removed after 24 h and stored frozen. After
24 h, 6-mm-diameter agarose constructs were removed,
stored frozen until the end of the experiment and then
digested with papain and agarase as described above.
Similarly, for monolayer cultures
35SO4 supplement media
were added at days 1, 4, 8, 11 and 15. After 24 h, the media
and monolayer extract samples were removed and frozen
before analysis.
Alcian blue precipitation onto ﬁlters (Millipore,
Watford, UK) was used to determine the incorporation of
35SO4 into the newly synthesised sGAG in the agarose
digest, the monolayer samples and all the associated media.
The incorporation was normalised to the total DNA mea-
surements calculated using the Hoescht 33258 assay as
previously described [1].
3 Results
3.1 Inﬂuence of PLIUS intensity on cell viability
After 9 days in culture, cell viability for agarose constructs
was greater than 85% throughout the depth of the construct.
PLIUS at SATA intensities of 30–100 mW/cm
2 had no
effect on cell viability (Fig. 1). However, at SATA inten-
sities of 200 and 300 mW/cm
2, a signiﬁcant loss in via-
bility occurred towards the bottom of the agarose
constructs. Thus, at a SATA intensity of 300 mW/cm
2,
there was 100% cell death in the agarose, adjacent to the
PLIUS transducer.
3.2 Inﬂuence of PLIUS on sGAG synthesis in agarose
culture
The temporal change in total sGAG content are shown in
Fig. 2 for chondrocytes in agarose constructs exposed to
Fig. 1 Cell viability proﬁles through chondrocyte–agarose gels
exposed to PLIUS for 20 min/day for 9 days. PLIUS was applied at
SATA intensities of 30, 100, 200 and 300 mW/cm
2. Controls were
not exposed to PLIUS. Viability is expressed as the percentage of
viable cells per ﬁeld of view for adjacent ﬁelds of view throughout the
3 mm thickness of the agarose gel. Data points represent mean
viability values (n = 6)
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2 (Fig. 2b) with
corresponding control values. Cummulative release of
sGAG into the associated culture media is also presented.
For all treatment groups, there was a steady synthesis of
sGAG over the 16-day culture period, with approximately
80% retained within the agarose construct and the rest
released to the associated culture media. Statistical analysis
was conducted using the data from three repeat experi-
ments and a total of 14 bovine joints. The application of
PLIUS at a SATA intensity of 30 mW/cm
2, showed no
statistically signiﬁcant effect on the total synthesis of
sGAG or the retention within the agarose constructs at any
of the time points (P[0.05, paired two-tailed T-test)
(Fig. 2c). Similarly, at 100 mW/cm
2, PLIUS had no effect
with the exception of a 20% increase in total sGAG content
at day 2 (P\0.05) (Fig. 2c).
The incorporation of SO4 into newly synthesised sGAG
for chondrocytes exposed to 30 and 100 mW/cm
2 is pre-
sented graphically in Fig. 3. At days 2, 5, 9 and 16, but not
day 12, SO4 incorporation over the previous 24 h was
signiﬁcantly reduced in cells exposed to 30 mW/cm
2
PLIUS compared to controls (P\0.05). By contrast,
PLIUS at 100 mW/cm
2 was associated with statistically
signiﬁcant increases in SO4 incorporation measured at day
2 and day 16. At all other time points, differences were not
statistically signiﬁcant. Studies conducted with PLIUS
applied twice a day showed no difference from the once-a-
day protocol used here (data not shown) [42].
3.3 Inﬂuence of PLIUS on sGAG synthesis
in monolayer culture
Chondrocytes in monolayer synthesised sGAG, with the
majority, approximately 50–70%, released to the media.
There were no statistically signiﬁcant differences, at any
time point, in the total sGAG levels between control cul-
tures and those exposed to PLIUS at either 30 or 100 mW/
cm
2 (Fig. 4). Similarly, PLIUS has no statistically signiﬁ-
cant effects on SO4 incorporation at any of the time points
studied (Fig. 5).
4 Discussion
The majority of previous studies examining the effects
of PLIUS on chondrocytes have used monolayer cultures
[7, 18, 35, 36]. However, such an approach has a number of
biological and biophysical limitations. First, chondrocytes
in monolayer are known to lose their chondrocytic phe-
notype and become more ﬁbroblastic in nature, with
associated alterations in cytoskeletal organisation and
changes in matrix synthesis. In addition, monolayer cul-
tures may be more susceptible to artefacts associated with
PLIUS. For example, heating occurs due to attenuation of
the ultrasound in the plastic encasing the transducers and
the base of the cell culture six-well plate. Indeed, a pre-
vious study has reported a slight increase in the global
temperature of the media within a single well [14]. Whilst
this temperature rise may not be sufﬁcient to activate heat
Fig. 2 Effect of PLIUS on cumulative sGAG content produced by
chondrocytes over a 16-day culture period in agarose. PLIUS was
applied for 20 min each day from day 1. Data plotted separately for
sGAG retained within agarose construct and released to associated
culture media for control cells and those exposed to PLIUS at 30
(a) and 100 mW/cm
2 (b). Data for PLIUS treated chondrocyte–
agarose constructs has also been plotted as a percentage of that
measured for corresponding untreated controls (c). Values represent
mean ± standard deviation for three separate repeat experiments.
Statistically signiﬁcant differences are indicated at * P\0.05
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metabolism of the cells directly adhered to cell culture
plastic. Another potential artefact with monolayer cultures
is the development of standing waves caused by con-
structive interference associated with the reﬂection of the
ultrasound between the air–media interface and the media–
plastic interface [14]. Standing waves may generate ﬂuid
shear forces, which are known to modulate chondrocyte
metabolism and matrix synthesis [23]. In addition, the
reﬂection of the ultrasound signal back into the transducer
may increase the heating effects. Thus, some studies have
employed PLIUS systems in the absence of an air–media
interface to ensure improved control of the ultrasound
signal, as well as using ultrasound-absorbing material to
eliminate multiple reﬂections [15, 19, 30, 46].
There is, therefore, increasing interest in understanding
the effects of PLIUS on chondrocytes seeded within 3D
scaffolds such as agarose, alginate and chitosan. Of these,
the chondrocyte–agarose model has been particularly well
characterised and is extensively used for examining the
effect of mechanical stimulation on chondrocytes. Chon-
drocytes cultured in agarose adopt a rounded morphology
necessary for the maintenance of chondrocytic phenotype,
as shown by the synthesis of cartilage-speciﬁc aggrecan
proteoglycan and type II collagen [2, 3]. For this reason,
agarose has also been proposed as a scaffold for cartilage
tissue engineering [28, 40] with encouraging clinical out-
comes using chondrocytes embedded in a composite aga-
rose-alginate hydrogel [39]. Hence, this study investigated
the effect of PLIUS on isolated chondrocytes seeded in
agarose gel cast within a six-well plate mounted above an
array of ultrasound transducers. The use of agarose is rel-
evant both as a potential tissue-engineered scaffold and as a
model for examining the therapeutic beneﬁt of ultrasound
for chondrocytes within a variety of 3D scaffolds pro-
posed for cartilage tissue engineering. Comparative studies
were also conducted using adult bovine chondrocytes
cultured in monolayer following protocols described by
Parvizi et al. [35].
Fig. 3 Effect of PLIUS at 30 and 100 mW/cm
2 on SO4 incorporation
over 24 h normalised to corresponding untreated controls (100%) for
chondrocytes cultured in agarose for up to 16 days. PLIUS was
applied for 20 min each day from day 1. Values represent
mean ± standard deviation for 14 replicate specimens from two
separate experiments. Statistically signiﬁcant differences are indi-
cated at * P\0.05
Fig. 4 Effect of PLIUS at 30 and 100 mW/cm
2 on total cumulative
sGAG content (cell extract plus media) produced by chondrocytes
over an 8-day culture period in monolayer. PLIUS was applied for
20 min each day from day 3. Data for PLIUS treated chondrocytes in
monolayer has been plotted as a percentage of that measured for
corresponding untreated controls. Values represent mean ± standard
deviation for 12 replicate specimens from two separate experiments.
There were no statistically signiﬁcant differences between PLIUS-
treated constructs and corresponding controls
Fig. 5 Effect of PLIUS at 30 and 100 mW/cm
2 on SO4 incorporation
over 24 h normalised to corresponding untreated controls (100%) for
chondrocytes over an 8-day culture period in monolayer. PLIUS was
applied for 20 min each day from day 3. Data for PLIUS treated
chondrocytes in monolayer has been plotted as a percentage of that
measured for corresponding untreated controls. Values represent
mean ± standard deviation for 12 replicate specimens from two
separate experiments. There were no statistically signiﬁcant differ-
ences between PLIUS-treated constructs and corresponding controls
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have generally used a SATA intensity of 30 mW/cm
2
which has been shown to be effective for treatment of bone
fractures. However, modelling studies reveal that the
exposure of knee joints to ultrasound at the clinical inten-
sity of 30 mW/cm
2 is likely to result in a tissue level
intensity of only 10 mW/cm
2 [43]. Among those studies
that report that PLIUS up-regulates chondrocyte metabo-
lism, there is some disagreement as to whether intensity
modulates this effect. Thus, some studies report a directly
proportional relationship between intensity and cell activity
[6, 17], others suggest that lower intensities are more
effective [40, 46], while some other studies indicate little
difference between intensity levels [35] or no effect at all
[6, 10]. This study demonstrated that viability in agarose
was maintained at SATA intensities up to 100 mW/cm
2,
but was reduced at 200 and 300 mW/cm
2, particularly for
those cells located closer to the underlying ultrasound
transducer (Fig. 1). This suggests that the cell death may be
the result of attenuation heating in the transducer and/or the
six-well plate, although other mechanisms, such as cavi-
tation, cannot be excluded. Based on these results, all the
subsequent studies were restricted to two intensity levels,
namely 30 and 100 mW/cm
2.
Preliminary studies found that PLIUS at either 30 or
100 mW/cm
2 had no effect on cell proliferation in either
monolayer or agarose cultures as assessed by total DNA
content and incorporation of [
3H]thymidine (data not
shown) [42]. This is in agreement with the majority of
previous studies. In terms of the synthesis of sGAG, this
study revealed that PLIUS at 30 mW/cm
2 for 20 min/day,
had no stimulatory effect on adult bovine articular chon-
drocytes cultured in either agarose gel (Figs. 2, 3)o r
monolayer (Figs. 4, 5). Indeed, PLIUS signiﬁcantly
reduced the rate of SO4 incorporation for cell–agarose
constructs at days 2, 5, 9 and 16, although this was not
associated with a reduction in total sGAG content. At
100 mW/cm
2 the application of PLIUS to cells in agarose
only induced a statistically signiﬁcant increase in SO4
incorporation with an associated increase in sGAG content,
but only at day 2. For chondrocytes cultured in monolayer,
PLIUS at 100 mW/cm
2 had no effect on sGAG synthesis
(Figs. 4, 5).
These ﬁndings are in agreement with a few previous
studies suggesting that PLIUS has, at best, a minimal
stimulatory effect on chondrocyte matrix production
[17, 21, 46]. However, the data appear to conﬂict with the
other studies which suggest that ultrasound induces an
up-regulation of chondrocyte aggrecan gene expression,
incorporation of SO4 into the newly formed sGAG, and
downstream sGAG accumulation [21, 33, 35, 40, 44]. In
particular, the pioneering study by Parvizi et al. [35]i s
frequently cited as showing that PLIUS stimulates matrix
production by rat chondrocytes in monolayer. However, in
agreement with this study, Parvizi et al. report no statisti-
cally signiﬁcant difference in sGAG content between
PLIUS-treated and control cultures. This previous study
did ﬁnd a signiﬁcant difference in the rate of change of
sGAG content, but this appears to be due to the lower
initial level of sGAG in the PLIUS treated samples. Nev-
ertheless, in contrast to this study, similar experiments with
bovine patella chondrocytes in monolayer show SO4
incorporation increased approximately twofold after
3–5 days of PLIUS exposure at 10 min/day [20]. The dif-
ference may be due to the use of a higher ultrasound
intensity of 580 mW/cm
2, which did not result in cell
death, possibly due to the use of a water bath system. The
stimulatory effect in this and other studies might also be
attributed to the utilisation of different cell types. Indeed,
studies reporting a stimulatory effect of PLIUS have fre-
quently employed neonatal, embryonic and mesenchymal
stem cells (MSCs) [9, 32, 46]. Such populations are likely
to be more metabolically active than skeletally mature
cells, such as those used in the present and other studies,
which have reported minimal or no stimulatory effect of
PLIUS [6, 10]. This is supported by studies showing that
human articular chondrocytes from older donors are less
responsive to PLIUS stimulation in agarose compared to
cells from younger donors [40]. However, the use of
skeletally mature cells is relevant to the clinical situation,
where the majority of patients seeking surgical intervention
for cartilage injury are adults. Tissue engineering strategies
would preferentially utilise autologous adult cells although
an alternative approach might be to employ PLIUS to
stimulate autologous MSCs into chondrogenesis. Indeed it
has been reported that PLIUS enhances chondrogenic dif-
ferentiation [25] and stimulates proteoglycan and collagen
expression for human MSCs cultured in 3D scaffolds [38].
In this study, there was notable variation between
replicate experiments with different cell isolations. Inter-
estingly, Kopakkala-Tani et al. also reported that PLIUS
induced different effects on cells from different animals
[20]. This variability may reﬂect important person to
person variability in the beneﬁt provided by any thera-
peutic approach using autologous cells. Although it is not
clear as to what is responsible, one possibility is that
ultrasound is only effective in tissue from a damaged or
inﬂamed joint. This is supported by the fact that PLIUS is
very effective in the treatment of fracture non-unions
[4, 16, 22], but has been shown to have no effect on
increasing bone mass in osteoporosis where there is no
injury response [26]. Similarly, ultrasound is reported to
have a greater effect on osteoarthritic human chondro-
cytes in monolayer compared to cells isolated from non-
osteoarthric tissue from the same joint, although the study
found no effect in cartilage explants [21]. In addition,
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osteochondral injury [8] and reduces the severity and
progression of osteoarthritis with an increase in collagen
II gene expression [13, 31]. The mechanism may involve
Rac1 and Wnt signalling which are activated by PLIUS
and involved in membrane protrusion and cell migration
associated with mammalian wound healing [27, 34]. Thus,
as previously suggested, the therapeutic beneﬁt of PLIUS,
may be dependent on the presence of an injury or wound
healing response involving Rac1-mediated cell migration.
Indeed, this may explain the conﬂicting results from
previous studies which might occur because of differing
degrees of injury response present within different in vitro
or in vivo model systems.
In conclusion, this study reveals that PLIUS at 30 mW/
cm
2 had no net effect on the synthesis of sGAG by adult
bovine articular chondrocytes cultured in either agarose
or monolayer culture. However, at 100 mW/cm
2, PLIUS
induced an initial transient up-regulation of SO4 incorpo-
ration and sGAG content in agarose constructs. This initial
stimulatory effect of 100 mW/cm
2 PLIUS, may be asso-
ciated with some form of transient injury response caused
by enzymatic isolation and seeding in agarose. This may
provide a limited window of opportunity to stimulate
sGAG production, at SATA intensities above 30 mW/cm
2.
These ﬁndings have important implications for the thera-
peutic potential of PLIUS for adult articular cartilage
regeneration and tissue engineering as well as under-
standing the potential mechanisms through which PLIUS
may activate a healing response in other systems.
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